Collaboration offers end-to-end support from donor sourcing to manufacturing More: eXmoor and Anthony Nolan partner to streamline cell therapy development Source: News
read moreIonis has hit a “home run,” according to analysts at Citi, with data in two phase 3 trials that show the ability of Tryngolza to reduce triglycerides and acute pancreatitis events in individuals with severe hypertriglyceridemia. More: Ionis hits it
read moreVerquvo failed to deliver a composite cardiovascular benefit for certain patients with heart failure, with investigators noting seemingly divergent results on two key measures. More: Merck, Bayer's Verquvo posts perplexing trial fail in patients with stable HFrEF Source: fierce
read moreAfter musing on a fall IPO just last week, Stada is instead being picked up by CapVest Partners in a deal that reportedly values the business at around 10 billion euros ($11.6 billion), according to Reuters. More: CapVest Partners snaps
read more
New subcutaneous autoinjector offers at-home treatment option for patients More: FDA approves LEQEMBI IQLIK for maintenance dosing in early Alzheimer’s disease Source: News
read more
MHRA grants conditional authorisation for treatment targeting mantle cell lymphoma More: Lilly receives UK approval for pirtobrutinib in relapsed blood cancers Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals